Appointment of Chief Financial Officer
Tony Ratcliffe appointed as Chief Financial Officer and Executive Director with immediate effect.
Select text to share a quote on X · sign in to keep highlights & notes in your RCN notes
Redcentric plc (AIM: RCN), a leading UK IT managed services provider, is pleased to announce the appointment of Tony Ratcliffe as Chief Financial Officer and Executive Director with immediate effect.
Tony has over 25 years' senior financial management experience with fast growing technology and service companies, including on AIM and Nasdaq. This experience extends across a number of high growth sectors, including healthcare, software and materials science. Most recently, Tony was CFO of SourceBio International, a healthcare technology group, where he led its AIM IPO and a successful restructuring which contributed to a fourfold increase in revenues and significant increase in profitability over a two-year period. In prior CFO roles, Tony has acquired varied operational, transactional, and strategic experience and driven significant growth, both organically and via M&A, with an ultimate focus on creating value for shareholders.
Tony qualified as a Chartered Accountant with KPMG and has an MBA from Heriot-Watt University, Edinburgh.
Michelle Senecal De Fonseca, CEO, commented: "I would like to welcome Tony to the Redcentric Board and look forward to working with him as we look to grow the business. Tony has many years' experience in growing technology companies and driving shareholder value, which will bring valuable expertise to Redcentric."
Additional information pursuant to Schedule Two, paragraph (g) of the AIM Rules for companies. Anthony ('Tony') James Ratcliffe, aged 61, is currently or has previously been a director of the following companies within the past five years.
| Current directorships | Previous directorships within the past five years |
| Consilium Financial Limited 7 Elements Limited Piksel Industry Solutions Limited Hotchilli Internet Limited Redcentric Solutions Limited | SourceBio International Limited (formerly SourceBio International plc) Source BioScience Inc Source BioScience Ireland Limited Source Bioscience Limited Source BioScience (Storage) Limited Source Bioscience UK Limited Source BioScience (Healthcare) Limited Select Pharma Laboratories Limited Source BioScience (Orchard Place) Limited Source BioScience (Cryobank) Limited Geneservice Limited Equipmake Holdings PLC Equipmake Limited Fairfield Imaging Limited Fairfield Telepathology Limited Kinetic Imaging Limited Cryobank Guarantor Limited Source BioScience Scotland Limited LDPath Limited SourceBio International Inc Source Genomics Limited |
Tony was, until 1 March 2020, a director of Metalysis Limited, whose principal shareholder was one of the Woodford funds. Following the collapse of the Woodfood group, Metalysis was put into administration on 3 June 2019. Following the sale of assets, the process of administration was subsequently completed on 9 June 2021, with amounts outstanding to creditors of c.£5 million.
Save as set out in this announcement, there are no further details to be disclosed in pursuant to Schedule Two, paragraph (g) of the AIM Rules for companies.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.